3.1. Primary Outcomes
An almost equal number of patients with COVID-19 in each group were transferred to the ICU or died during hospitalization—24/113 (21.2%) lactoferrin-treated patients vs. 21/105 (20.0%) patients in the placebo group; proportion difference = 1.20% (95% CI: −9.63–11.85), 